Fixed Phage
Leading the design, development and commercialisation of applications, which use stabilised phage to
About Fixed Phage
Fixed Phage leads the design, development and commercialisation of applications, which use stabilised phage to solve bacterial challenges.
Their technology binds and stabilises phage, opening the door to their widespread practical application.
Phages are sustainable, naturally based and completely harmless to plants, animals and humans.
Bacteriophage (phage) remove undesirable bacteria whilst leaving the rest of the microbiome intact. The Fixed Phage technology irreversibly binds phage to almost any surface. This immobilisation allows phage delivery to targeted locations, extending the antibacterial activity of natural phage from days to years.
The technology can be used in a number of fields including:
- Animal Health
- Personal Health
- Harvest Health
- Personal Care and Cosmetics
- Human Health
Our Team
Fixed Phage have considerable experience and knowledge in the senior management team. They are led by CEO David Browning, who has over 40 years of experience in commercialising innovative healthcare products.
The Chief Scientific Officer is Dr Jason Clark, one of the world’s leading industrial phage scientists, who has spent over ten years in phage companies.
Their Business and Finance Manager is Marta Zembinskyte who has considerable experience in financial forecasting, planning, analysis with blue-chip companies including Sainsbury’s Bank, PricewaterhouseCoopers.
Chris Bindon is Technical Manager. He has 25 years of blue-chip pharmaceutical and consumer healthcare, R&D-led operational management. and is a Lean Six Sigma practitioner (Black Belt).
Our Board of Directors is also packed with experience including:
- JOHN CARNEY – Chair
- ALEC MACKIE – Company Secretary
- TREVOR LANGLEY – Co-Founder & Deputy Chair
- DR MIKE MATTEY – Co-Founder and NED
- ALBERT NICHOLL – NED
- SIMON HUNT – NED
- JO PISANI – Advisory Group
